Resources

U.S. Food and Drug Administration Links

Potential Risk of Variant Creutzfeldt-Jakob Disease (vCJD) From Plasma-Derived Products
From the United States Food and Drug Administration. Center for Biologics Evaluation and Research. CBER regulates biological products (e.g., blood and blood products, and tissues). This site provides guidance for organizations involved in blood safety.

Guidance for Industry: Revised Preventive Measures to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease (CJD) and Variant Creutzfeldt-Jakob Disease (vCJD) by Blood and Blood Products
From the United States Food and Drug Administration. Center for Biologics Evaluation and Research. CBER regulates biological products (e.g., blood and blood products, and tissues). This site provides guidance for organizations involved in blood safety.

Draft Guidance for Industry: Amendment (Donor Deferral for Transfusion in France Since 1980) to “Guidance for Industry: Revised Preventive Measures to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease (CJD) and Variant Creutzfeldt-Jakob Disease (vCJD) by Blood and Blood Products”
From the United States Food and Drug Administration. Center for Biologics Evaluation and Research. CBER regulates biological products (e.g., blood and blood products, and tissues). This site provides guidance for organizations involved in blood safety.

Recommendations for the Use of Vaccines Manufactured with Bovine-Derived Materials
Information about bovine-derived materials used in vaccine manufacturing.

United States Department of Agriculture Links

Bovine Spongiform Encephalopathy (BSE)
From the Animal and Plant Health Inspection Service, an agency within the United States Department of Agriculture.